CYP19A1 and ductal breast carcinoma in situ: Treatment options currently recommended by the National Comprehensive Cancer Network (NCCN) include mastectomy with sentinel lymph node biopsy, lumpectomy with radiation, or lumpectomy alone with the potential addition of Tamoxifen and aromatase inhibitors in post-menopausal women with hormone receptor-positive DCIS [8,9].